314 related articles for article (PubMed ID: 22268848)
1. The genetics of uveal melanoma: an emerging framework for targeted therapy.
Harbour JW
Pigment Cell Melanoma Res; 2012 Mar; 25(2):171-81. PubMed ID: 22268848
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract][Full Text] [Related]
3. Uveal melanoma: From diagnosis to treatment and the science in between.
Chattopadhyay C; Kim DW; Gombos DS; Oba J; Qin Y; Williams MD; Esmaeli B; Grimm EA; Wargo JA; Woodman SE; Patel SP
Cancer; 2016 Aug; 122(15):2299-312. PubMed ID: 26991400
[TBL] [Abstract][Full Text] [Related]
4. Ocular melanoma: an overview of the current status.
Jovanovic P; Mihajlovic M; Djordjevic-Jocic J; Vlajkovic S; Cekic S; Stefanovic V
Int J Clin Exp Pathol; 2013; 6(7):1230-44. PubMed ID: 23826405
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA dysregulation in uveal melanoma: a new player enters the game.
Li Z; Yu X; Shen J; Jiang Y
Oncotarget; 2015 Mar; 6(7):4562-8. PubMed ID: 25682876
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity and molecular landscape of melanoma: implications for targeted therapy.
Beigi YZ; Lanjanian H; Fayazi R; Salimi M; Hoseyni BHM; Noroozizadeh MH; Masoudi-Nejad A
Mol Biomed; 2024 May; 5(1):17. PubMed ID: 38724687
[TBL] [Abstract][Full Text] [Related]
7. Genetic Landscape and Emerging Therapies in Uveal Melanoma.
Seedor RS; Orloff M; Sato T
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771666
[TBL] [Abstract][Full Text] [Related]
8. Pathology and genetics of uveal melanoma.
Griewank KG; Murali R
Pathology; 2013 Jan; 45(1):18-27. PubMed ID: 23222249
[TBL] [Abstract][Full Text] [Related]
9. The genetics of uveal melanoma: current insights.
Helgadottir H; Höiom V
Appl Clin Genet; 2016; 9():147-55. PubMed ID: 27660484
[TBL] [Abstract][Full Text] [Related]
10. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
[TBL] [Abstract][Full Text] [Related]
11. Genetic and clinico-pathologic analysis of metastatic uveal melanoma.
Griewank KG; van de Nes J; Schilling B; Moll I; Sucker A; Kakavand H; Haydu LE; Asher M; Zimmer L; Hillen U; Thompson JF; Scolyer RA; Schadendorf D; Murali R
Mod Pathol; 2014 Feb; 27(2):175-83. PubMed ID: 23887304
[TBL] [Abstract][Full Text] [Related]
12. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives.
Buder K; Gesierich A; Gelbrich G; Goebeler M
Cancer Med; 2013 Oct; 2(5):674-86. PubMed ID: 24403233
[TBL] [Abstract][Full Text] [Related]
13. Melanoma susceptibility genes and risk assessment.
Marzuka-Alcalá A; Gabree MJ; Tsao H
Methods Mol Biol; 2014; 1102():381-93. PubMed ID: 24258989
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in clinical presentation and prognosis of uveal melanoma.
Zloto O; Pe'er J; Frenkel S
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):652-6. PubMed ID: 23197684
[TBL] [Abstract][Full Text] [Related]
15. Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.
Johansson P; Aoude LG; Wadt K; Glasson WJ; Warrier SK; Hewitt AW; Kiilgaard JF; Heegaard S; Isaacs T; Franchina M; Ingvar C; Vermeulen T; Whitehead KJ; Schmidt CW; Palmer JM; Symmons J; Gerdes AM; Jönsson G; Hayward NK
Oncotarget; 2016 Jan; 7(4):4624-31. PubMed ID: 26683228
[TBL] [Abstract][Full Text] [Related]
16. Genetic landscape of uveal melanoma.
Rodrigues MJ; Stern MH
J Fr Ophtalmol; 2015 Jun; 38(6):522-5. PubMed ID: 25976133
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in prognostic and predictive testing in uveal melanoma.
Field MG; Harbour JW
Curr Opin Ophthalmol; 2014 May; 25(3):234-9. PubMed ID: 24713608
[TBL] [Abstract][Full Text] [Related]
19. Genomic, prognostic, and cell-signaling advances in uveal melanoma.
Harbour JW
Am Soc Clin Oncol Educ Book; 2013; ():388-91. PubMed ID: 23714557
[TBL] [Abstract][Full Text] [Related]
20. Characterization, treatment, and outcome of uveal melanoma in the first two years of life.
Yousef YA; Alkilany M
Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):1-5. PubMed ID: 25300563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]